COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Is there a glimmer of light at the end of the tunnel?

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Nov 12, 2024 8:41am

67 Views

Post# 36307940

RE:Is there a glimmer of light at the end of the tunnel?

With the failure of the diagnostic test and potential licensing deal they don't appear to have the cash now for AEZS's pipeline assets and have stopped development. It's back to CZO's assets but delays there. Who they can get as the new President and CEO will help tell the story as they wait for key data for the avenanthramide pill, and PGX scale-up, etc.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 21, 2024